Press "Enter" to skip to content

New patent expiration for Blue Earth drug AXUMIN

2
Copyright © DrugPatentWatch. Originally published at New patent expiration for Blue Earth drug AXUMIN

Annual Drug Patent Expirations for AXUMIN
Annual Drug Patent Expirations for AXUMIN

Axumin is a drug marketed by Blue Earth and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.

This drug has thirty-seven patent family members in sixteen countries.

The generic ingredient in AXUMIN is fluciclovine f-18. One supplier is listed for this compound. Additional details are available on the fluciclovine f-18 profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Blue Earth drug AXUMIN
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions